Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Fzd9 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Fzd9 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of FZD9 mRNA | CTD | PMID:22206623 | Fzd9 | Rat | 17beta-estradiol | increases expression | ISO | FZD9 (Homo sapiens) | 6480464 | Estradiol results in increased expression of FZD9 mRNA | CTD | PMID:31614463 | Fzd9 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | ISO | FZD9 (Homo sapiens) | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of FZD9 mRNA | CTD | PMID:23146750 | Fzd9 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | FZD9 (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FZD9 mRNA | CTD | PMID:23146750 | Fzd9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FZD9 mRNA | CTD | PMID:32109520 | Fzd9 | Rat | 2-palmitoylglycerol | increases expression | ISO | FZD9 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of FZD9 mRNA | CTD | PMID:37199045 | Fzd9 | Rat | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | FZD9 (Homo sapiens) | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FZD9 mRNA | CTD | PMID:23146750 | Fzd9 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | FZD9 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Fzd9 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Fzd9 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of FZD9 mRNA | CTD | PMID:30951980 | Fzd9 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of FZD9 mRNA | CTD | PMID:33150595 | Fzd9 | Rat | 6-propyl-2-thiouracil | increases methylation | EXP | | 6480464 | Propylthiouracil results in increased methylation of FZD9 promoter | CTD | PMID:33150595 | Fzd9 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of FZD9 mRNA | CTD | PMID:28959563 | Fzd9 | Rat | acrylamide | decreases expression | ISO | FZD9 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of FZD9 mRNA | CTD | PMID:32763439 | Fzd9 | Rat | alpha-Zearalanol | decreases expression | EXP | | 6480464 | Zeranol results in decreased expression of FZD9 mRNA | CTD | PMID:35163327 | Fzd9 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FZD9 mRNA | CTD | PMID:16483693 | Fzd9 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of FZD9 gene | CTD | PMID:28931070 | Fzd9 | Rat | benzo[a]pyrene | decreases expression | ISO | Fzd9 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of FZD9 mRNA | CTD | PMID:27195522 | Fzd9 | Rat | benzo[a]pyrene | affects expression | ISO | FZD9 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the expression of FZD9 mRNA | CTD | PMID:21714911 | Fzd9 | Rat | bis(2-chloroethyl) sulfide | decreases expression | ISO | Fzd9 (Mus musculus) | 6480464 | Mustard Gas results in decreased expression of FZD9 mRNA | CTD | PMID:15674843 | Fzd9 | Rat | bisphenol A | decreases expression | ISO | FZD9 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of FZD9 mRNA | CTD | PMID:23146750 | Fzd9 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FZD9 mRNA | CTD | PMID:34947998 | Fzd9 | Rat | bisphenol A | decreases expression | ISO | Fzd9 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of FZD9 mRNA | CTD | PMID:30245210 | Fzd9 | Rat | bisphenol A | decreases methylation | ISO | Fzd9 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of FZD9 promoter | CTD | PMID:27312807 | Fzd9 | Rat | bisphenol A | multiple interactions | ISO | FZD9 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Fzd9 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FZD9 mRNA | CTD | PMID:25181051 | Fzd9 | Rat | cadmium dichloride | increases expression | ISO | Fzd9 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of FZD9 mRNA | CTD | PMID:20478370 | Fzd9 | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of FZD9 mRNA | CTD | PMID:36928142 | Fzd9 | Rat | cadmium dichloride | decreases expression | ISO | FZD9 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of FZD9 mRNA | CTD | PMID:38382870 | Fzd9 | Rat | calciol | decreases expression | ISO | Fzd9 (Mus musculus) | 6480464 | Cholecalciferol results in decreased expression of FZD9 mRNA | CTD | PMID:16508948 | Fzd9 | Rat | cannabidiol | affects methylation | EXP | | 6480464 | Cannabidiol affects the methylation of FZD9 gene | CTD | PMID:30521419 | Fzd9 | Rat | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of FZD9 mRNA | CTD | PMID:18502319 | Fzd9 | Rat | choline | multiple interactions | ISO | Fzd9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Fzd9 | Rat | chromium(6+) | affects expression | ISO | Fzd9 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of FZD9 mRNA | CTD | PMID:28472532 | Fzd9 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of FZD9 mRNA | CTD | PMID:26577399|PMID:27523638 | Fzd9 | Rat | dexamethasone | multiple interactions | ISO | FZD9 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Fzd9 | Rat | diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of FZD9 mRNA | CTD | PMID:19130878 | Fzd9 | Rat | diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of FZD9 mRNA | CTD | PMID:18502319 | Fzd9 | Rat | dibutyl phthalate | increases expression | ISO | Fzd9 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of FZD9 mRNA | CTD | PMID:17361019|PMID:21266533 | Fzd9 | Rat | dieldrin | decreases expression | EXP | | 6480464 | Dieldrin results in decreased expression of FZD9 mRNA | CTD | PMID:19130878 | Fzd9 | Rat | Evodiamine | increases expression | ISO | FZD9 (Homo sapiens) | 6480464 | evodiamine results in increased expression of FZD9 mRNA | CTD | PMID:31835579 | Fzd9 | Rat | folic acid | multiple interactions | ISO | Fzd9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Fzd9 | Rat | fonofos | increases methylation | ISO | FZD9 (Homo sapiens) | 6480464 | Fonofos results in increased methylation of FZD9 promoter | CTD | PMID:22847954 | Fzd9 | Rat | FR900359 | decreases phosphorylation | ISO | FZD9 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of FZD9 protein | CTD | PMID:37730182 | Fzd9 | Rat | genistein | increases expression | ISO | Fzd9 (Mus musculus) | 6480464 | Genistein results in increased expression of FZD9 mRNA | CTD | PMID:32186404 | Fzd9 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of FZD9 mRNA | CTD | PMID:33387578 | Fzd9 | Rat | glutathione | multiple interactions | ISO | Fzd9 (Mus musculus) | 6480464 | [GCLM protein mutant form results in decreased abundance of Glutathione] which results in decreased methylation more ... | CTD | PMID:38830566 | Fzd9 | Rat | hydrazine | decreases expression | ISO | Fzd9 (Mus musculus) | 6480464 | hydrazine results in decreased expression of FZD9 mRNA | CTD | PMID:15282401 | Fzd9 | Rat | indometacin | multiple interactions | ISO | FZD9 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Fzd9 | Rat | L-methionine | multiple interactions | ISO | Fzd9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Fzd9 | Rat | lipopolysaccharide | increases expression | ISO | Fzd9 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of FZD9 mRNA | CTD | PMID:12057914 | Fzd9 | Rat | mifepristone | increases expression | ISO | FZD9 (Homo sapiens) | 6480464 | Mifepristone results in increased expression of FZD9 mRNA | CTD | PMID:17584828 | Fzd9 | Rat | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of FZD9 mRNA | CTD | PMID:19130878 | Fzd9 | Rat | niclosamide | decreases expression | ISO | FZD9 (Homo sapiens) | 6480464 | Niclosamide results in decreased expression of FZD9 mRNA | CTD | PMID:22576131 | Fzd9 | Rat | paracetamol | increases expression | ISO | FZD9 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of FZD9 mRNA | CTD | PMID:26690555 | Fzd9 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of FZD9 mRNA | CTD | PMID:33387578 | Fzd9 | Rat | parathion | increases methylation | ISO | FZD9 (Homo sapiens) | 6480464 | Parathion results in increased methylation of FZD9 promoter | CTD | PMID:22847954 | Fzd9 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Fzd9 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of FZD9 mRNA | CTD | PMID:37995155 | Fzd9 | Rat | perfluorooctanoic acid | decreases expression | ISO | FZD9 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of FZD9 mRNA | CTD | PMID:23146750 | Fzd9 | Rat | sunitinib | increases expression | ISO | FZD9 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of FZD9 mRNA | CTD | PMID:31533062 | Fzd9 | Rat | terbufos | increases methylation | ISO | FZD9 (Homo sapiens) | 6480464 | terbufos results in increased methylation of FZD9 promoter | CTD | PMID:22847954 | Fzd9 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of FZD9 mRNA | CTD | PMID:34492290 | Fzd9 | Rat | titanium dioxide | decreases expression | ISO | Fzd9 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of FZD9 mRNA | CTD | PMID:29264374 | Fzd9 | Rat | titanium dioxide | decreases methylation | ISO | Fzd9 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of FZD9 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Fzd9 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of FZD9 mRNA | CTD | PMID:33387578 | Fzd9 | Rat | triptonide | increases expression | ISO | Fzd9 (Mus musculus) | 6480464 | triptonide results in increased expression of FZD9 mRNA | CTD | PMID:33045310 | Fzd9 | Rat | urethane | increases expression | ISO | FZD9 (Homo sapiens) | 6480464 | Urethane results in increased expression of FZD9 mRNA | CTD | PMID:28818685 | Fzd9 | Rat | valproic acid | increases methylation | ISO | FZD9 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of FZD9 gene | CTD | PMID:29154799 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















